10.64 USD
+0.08 (+0.76%)
10.64 USD
0 (0%)
Overall VTRS gets a fundamental rating of 4 out of 10. We evaluated VTRS against 192 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of VTRS while its profitability can be described as average. VTRS has a bad growth rate and is valued cheaply.
1. Profitability
1.1 Basic Checks
VTRS had positive earnings in the past year.
In the past year VTRS had a positive cash flow from operations.
In multiple years VTRS reported negative net income over the last 5 years.
Each year in the past 5 years VTRS had a positive operating cash flow.
1.2 Ratios
VTRS has a Return On Assets of -9.73%. This is in the better half of the industry: VTRS outperforms 66.67% of its industry peers.
VTRS has a Return On Equity of -24.26%. This is in the better half of the industry: VTRS outperforms 63.54% of its industry peers.
VTRS has a better Return On Invested Capital (3.41%) than 80.73% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for VTRS is significantly below the industry average of 12.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.73% | ||
| ROE | -24.26% | ||
| ROIC | 3.41% |
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
1.3 Margins
VTRS has a better Operating Margin (9.34%) than 81.77% of its industry peers.
In the last couple of years the Operating Margin of VTRS has declined.
The Gross Margin of VTRS (39.36%) is comparable to the rest of the industry.
VTRS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.34% | ||
| PM (TTM) | N/A | ||
| GM | 39.36% |
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VTRS is destroying value.
Compared to 1 year ago, VTRS has less shares outstanding
The number of shares outstanding for VTRS has been increased compared to 5 years ago.
Compared to 1 year ago, VTRS has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.90, we must say that VTRS is in the distress zone and has some risk of bankruptcy.
VTRS's Altman-Z score of 0.90 is in line compared to the rest of the industry. VTRS outperforms 55.21% of its industry peers.
The Debt to FCF ratio of VTRS is 8.96, which is on the high side as it means it would take VTRS, 8.96 years of fcf income to pay off all of its debts.
VTRS has a Debt to FCF ratio of 8.96. This is in the better half of the industry: VTRS outperforms 78.65% of its industry peers.
A Debt/Equity ratio of 0.82 indicates that VTRS is somewhat dependend on debt financing.
VTRS has a worse Debt to Equity ratio (0.82) than 70.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 8.96 | ||
| Altman-Z | 0.9 |
ROIC/WACC0.45
WACC7.59%
2.3 Liquidity
VTRS has a Current Ratio of 1.35. This is a normal value and indicates that VTRS is financially healthy and should not expect problems in meeting its short term obligations.
VTRS has a worse Current ratio (1.35) than 73.96% of its industry peers.
VTRS has a Quick Ratio of 1.35. This is a bad value and indicates that VTRS is not financially healthy enough and could expect problems in meeting its short term obligations.
VTRS has a worse Quick ratio (0.79) than 82.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
The earnings per share for VTRS have decreased strongly by -14.65% in the last year.
The Earnings Per Share has been decreasing by -9.73% on average over the past years.
The Revenue has decreased by -6.14% in the past year.
VTRS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.09% yearly.
EPS 1Y (TTM)-14.65%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.67%
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%0.23%
3.2 Future
VTRS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.64% yearly.
VTRS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.14% yearly.
EPS Next Y-12.01%
EPS Next 2Y-3.03%
EPS Next 3Y0.91%
EPS Next 5Y2.64%
Revenue Next Year-6.08%
Revenue Next 2Y-2.31%
Revenue Next 3Y-1.04%
Revenue Next 5Y0.14%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
VTRS is valuated cheaply with a Price/Earnings ratio of 4.57.
VTRS's Price/Earnings ratio is rather cheap when compared to the industry. VTRS is cheaper than 97.40% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.15. VTRS is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 4.27, the valuation of VTRS can be described as very cheap.
Based on the Price/Forward Earnings ratio, VTRS is valued cheaper than 96.35% of the companies in the same industry.
VTRS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.12.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.57 | ||
| Fwd PE | 4.27 |
4.2 Price Multiples
95.31% of the companies in the same industry are more expensive than VTRS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, VTRS is valued cheaply inside the industry as 92.19% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.7 | ||
| EV/EBITDA | 6.26 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.03%
EPS Next 3Y0.91%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.58%, VTRS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 7.92, VTRS pays a better dividend. On top of this VTRS pays more dividend than 96.88% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, VTRS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.58% |
5.2 History
VTRS has been paying a dividend for at least 10 years, so it has a reliable track record.
VTRS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
The earnings of VTRS are negative and hence is the payout ratio. VTRS will probably not be able to sustain this dividend level.
DP-15.34%
EPS Next 2Y-3.03%
EPS Next 3Y0.91%
10.64
+0.08 (+0.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners85.59%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner Change-0.14%
Market Cap12.40B
Revenue(TTM)14.12B
Net Income(TTM)-3.69B
Analysts71.25
Price Target12.12 (13.91%)
Short Float %2.23%
Short Ratio2.66
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.58% |
Yearly Dividend0.48
Dividend Growth(5Y)N/A
DP-15.34%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.6%
Min EPS beat(2)5.83%
Max EPS beat(2)9.36%
EPS beat(4)3
Avg EPS beat(4)2.01%
Min EPS beat(4)-7.28%
Max EPS beat(4)9.36%
EPS beat(8)4
Avg EPS beat(8)1.01%
EPS beat(12)7
Avg EPS beat(12)1.49%
EPS beat(16)10
Avg EPS beat(16)1.8%
Revenue beat(2)2
Avg Revenue beat(2)1.72%
Min Revenue beat(2)1.3%
Max Revenue beat(2)2.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-4.31%
Max Revenue beat(4)2.14%
Revenue beat(8)2
Avg Revenue beat(8)-1.25%
Revenue beat(12)2
Avg Revenue beat(12)-1.88%
Revenue beat(16)2
Avg Revenue beat(16)-2.17%
PT rev (1m)7.72%
PT rev (3m)7.72%
EPS NQ rev (1m)-3.27%
EPS NQ rev (3m)-2.18%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)0.16%
Revenue NQ rev (1m)2.21%
Revenue NQ rev (3m)2.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.57 | ||
| Fwd PE | 4.27 | ||
| P/S | 0.88 | ||
| P/FCF | 7.7 | ||
| P/OCF | 6.26 | ||
| P/B | 0.82 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.26 |
EPS(TTM)2.33
EY21.9%
EPS(NY)2.49
Fwd EY23.42%
FCF(TTM)1.38
FCFY12.99%
OCF(TTM)1.7
OCFY15.98%
SpS12.11
BVpS13.05
TBVpS-6.21
PEG (NY)N/A
PEG (5Y)N/A
Graham Number26.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.73% | ||
| ROE | -24.26% | ||
| ROCE | 4.32% | ||
| ROIC | 3.41% | ||
| ROICexc | 3.53% | ||
| ROICexgc | 14.83% | ||
| OM | 9.34% | ||
| PM (TTM) | N/A | ||
| GM | 39.36% | ||
| FCFM | 11.41% |
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
ROICexc(3y)4.16%
ROICexc(5y)3.64%
ROICexgc(3y)17.86%
ROICexgc(5y)17.54%
ROCE(3y)5.12%
ROCE(5y)4.54%
ROICexgc growth 3Y-9.04%
ROICexgc growth 5Y-13.17%
ROICexc growth 3Y4.9%
ROICexc growth 5Y-4.57%
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
F-Score4
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 8.96 | ||
| Debt/EBITDA | 3.05 | ||
| Cap/Depr | 13.37% | ||
| Cap/Sales | 2.63% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 48.4% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 0.9 |
F-Score4
WACC7.59%
ROIC/WACC0.45
Cap/Depr(3y)14.64%
Cap/Depr(5y)17.2%
Cap/Sales(3y)2.72%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.65%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.67%
EPS Next Y-12.01%
EPS Next 2Y-3.03%
EPS Next 3Y0.91%
EPS Next 5Y2.64%
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%0.23%
Revenue Next Year-6.08%
Revenue Next 2Y-2.31%
Revenue Next 3Y-1.04%
Revenue Next 5Y0.14%
EBIT growth 1Y-2.47%
EBIT growth 3Y-4.1%
EBIT growth 5Y1.89%
EBIT Next Year-5.71%
EBIT Next 3Y0.26%
EBIT Next 5Y0.47%
FCF growth 1Y-20.35%
FCF growth 3Y-7.94%
FCF growth 5Y6.95%
OCF growth 1Y-19.49%
OCF growth 3Y-8.61%
OCF growth 5Y5.01%
VIATRIS INC / VTRS FAQ
What is the ChartMill fundamental rating of VIATRIS INC (VTRS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to VTRS.
Can you provide the valuation status for VIATRIS INC?
ChartMill assigns a valuation rating of 7 / 10 to VIATRIS INC (VTRS). This can be considered as Undervalued.
What is the profitability of VTRS stock?
VIATRIS INC (VTRS) has a profitability rating of 5 / 10.
Can you provide the financial health for VTRS stock?
The financial health rating of VIATRIS INC (VTRS) is 3 / 10.
Can you provide the expected EPS growth for VTRS stock?
The Earnings per Share (EPS) of VIATRIS INC (VTRS) is expected to decline by -12.01% in the next year.